ABATACEPT — all Canadian products
3 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ABATACEPT, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02282097 | ORENCIA | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | Intravenous | ABATACEPT 250 MG | Marketed | |
| 02402475 | ORENCIA | BRISTOL-MYERS SQUIBB CANADA | Solution | Subcutaneous | ABATACEPT 125 MG | Marketed | |
| 02461919 | ORENCIA | BRISTOL-MYERS SQUIBB CANADA | Solution | Subcutaneous | ABATACEPT 125 MG | Cancelled Pre Market |
Browse other molecules: